2022 USA Medical Device IIS Conference
Event summary
The 7th Annual US Medical Device Investigator Initiated Study Conference will bring together industry leaders to address current challenges and highlight solutions for a successful IIS program. This virtual conference will provide practical insights on reviewing IIS proposals, building viable relationships with external thought leaders, aligning IIS with corporate strategy and fulfilling the regulatory expectations.
For more information or to register, please email Rebecca Lanz.
Featured agenda item
FDA and Fraud and Abuse: Navigating Key Regulatory & Compliance Issues for IIS
Wednesday, July 13: 5:10 pm ET
Cooley partners Gina Cavalier and Sonia Nath will speak at this event.
Topics include
- The importance of distinguishing IIS grants from fee-for-service research
- Navigating informed consent and HIPAA authorizations
- FDA’s approach to regulating clinical trials for devices: significant vs. non-significant risk devices, the role of IRBs and human subject protection requirements
- FDA regulatory risks presented by IIS: ensure compliance with 21 C.F.R. Part 812, including restrictions on promotion and charges/costs recouped as part of study
- Best practices for IIS contracting
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.